Monitoring –Pending second assessment-Add. Data

MA- Monitoring-Expired

Back to Dashboard

No. Reference No. Brand Name Generic Name GMP Status Pathway Application Date Date 1st Assessment Date 2nd Assessment Time Monitoring
11361/2018NEVIHUANEVIRAPINE NOT APPLIED FULL ASSESSMENT
Round-1
2019-11-150000-00-0019,864 days
22003/2019PANTINPANTOPRAZOLE SODIUM NOT APPLIED FULL ASSESSMENT 2019-06-05
Application Date
2021-07-092021-07-191,812 days
32568/2019 KALFEN DICLOFENAC SODIUM INJECTION GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2019-07-16
Application Date
2021-06-172021-06-171,771 days
45209/2020FUCLO-1FLUCLOXACILLIN GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2020-07-13
Application Date
2021-08-212021-08-211,408 days
58605/2020ELMOX 125AMOXICILLIN APPLIED FOR GMP FULL ASSESSMENT
Round-1
2023-03-1319,864 days
60154/2021GYNEPILL LEVONORGESTREL NOT APPLIED FULL ASSESSMENT
Round-1
2023-03-1519,864 days
70250/2021CEFTRIAXONE IGCEFTRIAXONE GMP CERTIFICATE AVAILABLE FULL ASSESSMENT
Round-1
2022-08-3019,864 days
80897/2021RABEZOLRABEPRAZOLE SODIUM GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2021-02-11
Application Date
0000-00-000000-00-001,195 days
9855/2022DASATINIB NEAPOLIS-20DASATINIB GMP CERTIFICATE AVAILABLE FULL ASSESSMENT
Round-1
2024-03-1919,864 days
10856/2022DASATINIB NEAPOLIS-50DASATINIB GMP CERTIFICATE AVAILABLE FULL ASSESSMENT
Round-1
2024-03-1919,864 days
11857/2022DASATINIB NEAPOLIS-70DASATINIB GMP CERTIFICATE AVAILABLE FULL ASSESSMENT
Round-1
2024-03-1919,864 days
1217532-2022VIVIAN MR CHLORZOXAZONE + DICLOFENAC SODIUM + PARACETAMOL GMP CERTIFICATE AVAILABLE FULL ASSESSMENT
Round-1
2024-01-110000-00-0019,864 days
1317775-2022CAPECITABINE NEAPOLISCAPECITABINE GMP CERTIFICATE AVAILABLE FULL ASSESSMENT
Round-1
2024-03-1919,864 days
142288/2023DASATINIB NEAPOLIS 140DASATINIB GMP CERTIFICATE AVAILABLE FULL ASSESSMENT
Round-1
2024-03-1919,864 days